Answers are grounded in this paper and cite their sources.
On May 28, the Food and Drug Administration approved 18F-flortaucipir, also known as AV1451, under the trademark name Tauvid (Avid Radiopharmaceuticals), for estimation of the density and distribution of aggregated tau neurofibrillary tangles in adults with cognitive impairment who are being
No takes yet. Share an insight, caveat, or question.
Henryk Barthel (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: